← back to database
Global BioAccess Fund backs therapeutics and medical-device companies addressing serious unmet needs in oncology, immunology, cardiovascular disease, CNS, and rare disease. It most often invests from Series A to C, can lead or co-lead, and may invest up to $10 million over a company's lifespan.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Investing team
Bruce RobertsManaging Partner
Dave PraharajSenior Associate
Kevin CyrResearch Associate
Lisa WisniewskiManaging Director
Sonia GulatiPrincipal
Ted MoonManaging Partner